Posts by acn:

Vyasa Yoga SG Marks Silver Jubilee with International Wellness Conference

SINGAPORE, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Vyasa Yoga SG, Singapore’s leading yoga institute, proudly celebrated its Silver Jubilee this month, marking 25 years of transforming lives through yoga and holistic health practices. Founded with S-VYASA, Vyasa Yoga SG has empowered thousands through its scientific, research-based yoga training and therapy programs, building a community of 3,000 certified yoga instructors and 500 yogi health therapists.The Silver Jubilee celebrations were inaugurated by esteemed guests, including Deputy High Commissioner of India Pooja Tillu, Neil Parekh, Chairman of Singapore Indian Chamber of Commerce and Industry (SICCI), Dr. H R Nagendra Guruji, Padma Shri awardee and renowned yoga guru, and Dr. Manjunath NK, Vice-President of the Asian Yoga Therapy Association, alongside Vyasa Yoga SG Founder, Manoj Thakur.To commemorate the milestone, Vyasa Yoga SG hosted the **International Conference on "Comprehensive Wellness Strategy" from October 19th to 20th, 2024 at the Galaxy Ballroom, CSC Tessensohn Club. The conference brought together 50 experts from 11 countries to explore integrating ancient yoga wisdom with modern science to enhance well-being. In her keynote address, Deputy High Commissioner Pooja Tillu emphasized the global relevance of yoga, stating: “Continue embracing yoga practice as a guiding light that will bring us together as a global family.”Manoj Thakur, Founder of Vyasa Yoga SG, reflected on the institute’s journey, “It has been a remarkable 25-year journey. Our success reflects the spirit of well-being we have cultivated in Singapore and beyond. We look forward to guiding people towards healthier, happier lives for many more years to come.”The event featured live yoga demonstrations and a special recognition ceremony to honor the institute’s significant contributions to health and wellness in Singapore. Vyasa Yoga SG is planning a series of events throughout the year to celebrate its 25th anniversary.About Vyasa Yoga SGEstablished to promote a healthy lifestyle through a scientific approach to yoga, Vyasa Yoga SG offers a variety of accredited programs for all ages and levels. With a mission to foster a culture of well-being, the institute continues to be at the forefront of holistic health in Singapore. For more information, visit  https://vyasasingapore.com/. For further media queries contact:Ganesh Somwanshiganesh@mettai.world Copyright 2024 ACN Newswire via SeaPRwire.com.

雲頂新耀宣佈伊曲莫德(VELSIPITY(R))獲批進入粵港澳大灣區 為潰瘍性結腸炎患者帶來新選擇

上海, 2024年10月25日 - (亞太商訊 via SeaPRwire.com) - 雲頂新耀(HKEX 1952.HK)是一家專注于創新藥研發、臨床開發、製造和商業化的生物製藥公司,今日宣佈,得益於「港澳藥械通」政策,伊曲莫德(VELSIPITY(R))正式獲得「粵港澳大灣區內地臨床急需進口港澳藥品批件」批准,可以在佛山複星禪誠醫院、中山大學附屬第一醫院兩家大灣區藥械通政策指定的醫療機構先行使用,後續該產品將在其他藥械通資質醫院陸續引入。伊曲莫德成為雲頂新耀第三款商業化新藥。伊曲莫德是一款創新的先進療法,於2024年4月獲得中國澳門特別行政區藥物監督管理局正式批准,每日一次口服,用於治療16歲及以上中重度活動性潰瘍性結腸炎(UC)患者。潰瘍性結腸炎是一種慢性、復發性、非特異性炎症性疾病,隨著病情延長,致殘率和結直腸癌發生率會不斷上升。到2030年,中國的潰瘍性結腸炎患者人數預計將比2019年增加一倍以上,達到約100萬人,患者對創新療法存在巨大未滿足需求。雲頂新耀首席執行官羅永慶表示:「非常高興看到伊曲莫德正式落地粵港澳大灣區,加快了該先進療法在中國大陸可及,為更多潰瘍性結腸炎患者帶來治療新選擇。雲頂新耀致力於將創新療法以最快速度帶給患者,未來,我們將繼續依託國家醫藥產業政策,發揮自身優勢,不斷探索創新模式來實現創新療法的加速落地。預計下半年,我們將在中國大陸地區遞交伊曲莫德的新藥上市許可申請,以進一步推進伊曲莫德的用藥可及性,造福更多患者。」伊曲莫德由Arena Pharmaceuticals公司開發,輝瑞於2022年完成了對Arena Pharmaceuticals的收購,而雲頂新耀早在2017年已從Arena獲得了在大中華區和韓國開發、生產和商業化伊曲莫德的獨家權利。伊曲莫德於去年10月和今年2月先後在美國和歐盟獲得新藥上市批准。作為雲頂新耀自身免疫性疾病領域的重磅產品,伊曲莫德亦於今年上半年陸續在中國澳門、新加坡獲得新藥上市批准。此外,雲頂新耀也於近期在中國香港遞交了伊曲莫德的新藥上市許可申請。伊曲莫德是歐盟首個且唯一獲批用於16歲及以上患者的新一代口服治療潰瘍性結腸炎藥物,也是目前唯一在全球Ⅲ期臨床試驗中證實對孤立性直腸炎有療效的藥物。在今年7月公佈的伊曲莫德治療中重度活動性潰瘍性結腸炎的亞洲多中心Ⅲ期臨床研究結果中,伊曲莫德取得了在誘導期和維持期治療的積極結果,且安全性良好,一天一次口服方便,為該藥物在臨床實踐中的廣泛應用進一步提供了堅實的科學依據和支援。關於伊曲莫德(VELSIPITY(R), etrasimod)伊曲莫德(VELSIPITY(R),etrasimod)是一種每日一次口服的高選擇性鞘氨醇-1-磷酸(S1P)受體調節劑,採用優化的藥理學設計,與S1P受體1、4和5結合。伊曲莫德目前已在美國、歐盟、加拿大、澳大利亞、英國、瑞士、以色列以及中國澳門和新加坡獲得新藥上市批准。關於雲頂新耀雲頂新耀是一家專注于創新藥研發、臨床開發、製造和商業化的生物製藥公司,致力於滿足亞洲市場尚未滿足的醫療需求。雲頂新耀的管理團隊在中國及全球領先製藥企業從事過高質量研發、臨床開發、藥政事務、化學製造與控制(CMC)、業務發展和商業化運營,擁有深厚的專長和豐富的經驗。雲頂新耀已打造多款疾病首創或者同類最佳的藥物組合,公司的治療領域包括腎科疾病、感染性和傳染性疾病、自身免疫性疾病。有關更多信息,請訪問公司網站:www.everestmedicines.com。前瞻性聲明本新聞稿所發佈的信息中可能會包含某些前瞻性表述,乃基於本公司或管理層在做出表述時對公司業務運營情況及財務狀況的現有看法、相信、和現有預期,可能會使用「將」、「預期」、「預測」、「期望」、「打算」、「計劃」、「相信」、「預估」、「確信」及其他類似詞語進行表述。這些前瞻性表述並非對未來業績的保證,會受到風險、不確定性及其他因素的影響,有些乃超出本公司的控制範圍,難以預計。因此,受我們的業務、競爭環境、政治、經濟、法律和社會情況的未來變化及發展等各種因素及假設的影響,實際結果可能會與前瞻性表述所含資料有較大差別。本公司及各附屬公司、各位董事、管理人員、顧問及代理未曾且概不承擔更新該稿件所載前瞻性表述以反映在本新聞稿發佈日後最新信息、未來項目或情形的任何義務,除非法律要求。 Copyright 2024 亞太商訊 via SeaPRwire.com.

Founder of Hua Medicine Dr. Chen Li was awarded the ‘C.C. Tan Life Science Industrialization Award’

HONG KONG, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) -  The 17th “C.C. Tan Life Science Award” ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the “C.C. Tan Life Science Industrialization Award”. C.C. Tan Life Science Award has the highest honor as “the Chinese Nobel” in life science. In the context of the comprehensive construction of Chinese-style modernization and the development of new productivity, this award is a high recognition of Dr. Chen Li's outstanding contributions to the industrialization of life science achievements, and a full affirmation of his decades-long efforts to promote conceptual, technological and institutional innovations in biopharmaceutical industry.Dr. Chen Li participated in the award ceremony and received the “C.C. TanLife Science Industrialization Award”.“C.C. Tan Life Science Award” was proposed by Mr. Tan Jiazhen, one of the founders of modern genetics in China and an outstanding scientist and educator in modern China, which was approved by the Ministry of Science and Technology of the People's Republic of China, aims to promote the industrialization of China's life sciences research results and stimulate life scientists to make innovations. Since its establishment in 2008, C.C. Tan Life Science Award has been awarded annually to scientists, professors and young scholars who have made achievements in life science in the People's Republic of China and have made outstanding contributions to the industrialization of scientific and technological achievements in life science.With more than 30 years of experience in new drug R&D and management, Dr. Chen Li returned to Shanghai from the U.S. in 2004, and participated in the establishment of Roche R&D Center, the first R&D center of a multinational company in Shanghai, bringing the advanced experience, talent concept, technical standards and quality management system of international new drug R&D to China, and contributing to the establishment of the environment of China's biopharmaceutical industry. Dr. Chen Li has contributed to the establishment of China's biopharmaceutical industry environment.In 2010, Dr. Chen Li founded Hua Medicine in Zhangjiang, Shanghai, with the original intention of “China leads the way in pharmaceutical innovation”, adhering to the tenet of “patients first, innovation first, and good medicines for the people”, focusing on the unmet clinical needs, and concentrating on the research and development of first-of-its-kind new medicines for diabetes. Dr. Chen Li is not only one of the earliest pioneers to leave his executive position at a multinational pharmaceutical company to start a local innovative drug company, but also a leader in developing First-in-Class drugs in China.In September 2022, under the leadership of Dr. Chen Li, Hua Medicine's world's first, China's first, Class I National New Drug, Dorzagliatin (trade name: HuaTangNing®), which took ten years to develop independently, received marketing approval from the State Food and Drug Administration (SFDA), making it the first Glucose Kinesin Activator (GKA) approved and marketed globally, and the tenth class of diabetes therapeutic drugs.As the world's first GKA drug, Dorzagliatin utilizes the new concept of “repairing sensing, reshaping homeostasis, and treating diabetes at the source” to achieve the improvement of blood glucose homeostasis dysregulation in patients with type 2 diabetes mellitus, and to bring a brand-new treatment for diabetes mellitus patients, which is a major breakthrough in the history of drug research and development of China in the field of major chronic diseases.  During the development of Hua Medicine, Dr. Chen Li has actively contributed to the development of China's biopharmaceutical industry. He has provided constructive opinions and suggestions for the system of marketing license holders and the system of patent linkage and patent protection, etc. He has cooperated with enterprises in the industry chain in the R&D and production of dorzagliatin to establish a joint innovation model, which has led to the development of the ecological development of the biopharmaceutical industry. In early 2024, Dr. Chen Li was awarded the first “Shanghai Outstanding Talent”. He is also the inventor of 119 granted invention patents and 270 invention patent applications and has been published more than 70 scientific papers in Nature Medicine, Lancet Diabetes Endocrinology, Nature Communication, PNAS, Diabetes, Obesity Metabolism, and the Journal of Biomedicine. PNAS, Diabetes, Obesity Metabolism, JACS, JOC and other international academic journals.About Hua MedicineHua Medicine is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin on hydrochloride-tolerated T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with varying degrees of renal function impairment (including end-stage renal impairment without dialysis). Hua Medicine partnered with Bayer, a leading global pharmaceutical company, to commercialize HuaTangNing in China, benefiting diabetic patients and their families.For more informationHua MedicineWebsite:  www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.

HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD’s The Liver Meeting 2024

HONG KONG, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, will present at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting®, taking place from November 15-19, 2024 in San Diego, California. The presentations include post-hoc analyses of the Phase 2a clinical study of berberine ursodeoxycholate (HTD1801), a gut-liver anti-inflammatory metabolic modulator, in patients with metabolic dysfunction-associated steatohepatitis (MASH) and comorbid type 2 diabetes mellitus (T2DM) (NCT03656744).“These data provide additional characterization of the efficacy and safety of HTD1801, a novel, multifunctional therapy being developed for the treatment of patients with MASH and T2DM. If further studies confirm these findings, HTD1801 could potentially offer a more effective solution for patients who do not respond adequately to GLP-1 receptor agonists.  In addition, the observations of improved GI tolerance over time suggests that HTD1801 may be an attractive option for long-term management of chronic conditions such as MASH and T2DM. The ongoing Phase 2b study (CENTRICITY, NCT05623189), fully enrolled in 1Q 2024, evaluates the histological benefit of HTD1801 in patients with MASH and T2DM. We look forward to announcing the CENTRICITY results which we expect in the first half of 2025,” said Dr. Leigh MacConell, Chief Development Officer of HighTide.“Efficacy of Berberine Ursodeoxycholate (HTD1801) Compared to Ongoing Use of GLP-1 Receptor Agonists in Patients with MASH and T2DM” (Abstract 3218, Poster Presented November 17th)About the Abstract: As GLP-1 Receptor Agonists (GLP-1RAs) are prominently used in patients with T2DM and gaining attention as a potential treatment for MASH, this post-hoc comparative efficacy analysis evaluated ongoing GLP-1RA use compared to newly initiated HTD1801 treatment. This analysis suggests that HTD1801 provides greater improvements in markers of liver injury and inflammation, glycemic control, weight loss, and lipid metabolism compared to ongoing GLP-1RA use. These findings are important as they suggest that HTD1801 could provide additional benefit to patients with MASH and T2DM, on concomitant GLP-1RA treatment.“Time Course of Onset, Incidence, and Prevalence of Gastrointestinal Adverse Events with HTD1801 (Berberine Ursodeoxycholate) in Patients with MASH and T2DM” (Abstract 3219, Poster Presented November 17th)About the Abstract: Across several indications, the most commonly occurring adverse events (AEs) in studies of HTD1801 have been mild to moderate gastrointestinal (GI) AEs, primarily diarrhea and nausea. The purpose of this post-hoc analysis was to characterize the time course and severity of GI AEs in patients with MASH and T2DM treated with HTD1801 for 18 weeks. Based on this analysis, the incidence of GI-related AEs peaks within the first 4 weeks of treatment, was mild to moderate in severity, and importantly, showed a decreasing incidence and prevalence over the course of treatment. These data demonstrate that HTD1801 is generally well-tolerated and with continued treatment, GI tolerance improves supporting its potential long-term use in chronic diseases, such as MASH.About HighTide TherapeuticsHighTide Therapeutics, Inc. (2511.HK) is a globally integrated biopharmaceutical company focusing on the discovery and development of first-in-class multifunctional multi-targeted therapies with chronic liver and metabolic diseases with significant unmet medical needs. The company is developing multiple clinical assets, including therapy for metabolic dysfunction-associated steatohepatitis (MASH), type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), and primary sclerosing cholangitis (PSC). Berberine ursodeoxycholate (HTD1801), the company’s lead drug candidate, received Fast Track designation from the U.S. FDA for both MASH and PSC, as well as Orphan Drug designation for PSC. In China, HTD1801 has been included in the National Major New Drug Innovation Program under the 13th Five-Year Plan for Major Technology Project.For more information, please visit www.hightidetx.com Copyright 2024 ACN Newswire via SeaPRwire.com.

DIFC continues to drive global action in shaping greener economies – Announces 2nd edition of the Future Sustainability Forum in Dubai

DUBAI, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Dubai International Financial Centre (DIFC), the leading global financial hub in the Middle East, Africa and South Asia (MEASA) region, announces the 2nd edition of the Future Sustainability Forum. Scheduled for 4 and 5 December 2024 at the Madinat Jumeirah, Dubai, the Forum will focus on mobilising sustainable practices, engaging in influential discussions on sustainable development, working towards environmental conservation, social equity and innovation.The announcement of the 2nd edition of the Forum underscores DIFC’s commitment to advancing UAE sustainability priorities alongside initiatives such as the DIFC Sustainable Finance Catalyst which aims to grow sustainable finance flows from Dubai to USD 100+ billion by 2030.The Forum coincides with the first anniversary of COP28 being hosted in the UAE and is set to attract over 3,000 participants. The event will mobilise industry leaders, investors, tech disruptors, and policymakers into achieving the United Nations Sustainable Development Goals (SDGs) and contributing to the delivery of the Paris Agreement, whilst aiming to channel investment flows between the global north and south to accelerate climate action.Alya Al Zarouni, Chief Operating Officer of DIFC Authority and Co-Chair of the Dubai Sustainable Finance Working Group, said, “The DIFC organised Future Sustainability Forum is a vital platform for collaborative action towards a more sustainable future. As the global economic landscape evolves, so must our commitment to responsible and inclusive growth. At DIFC, we are proud to be convening this gathering of industry leaders, innovators, and policymakers to address the most pressing environmental and social challenges of our time. Together, we can forge new pathways to a more resilient and sustainable future for financial services and other important industries.”Dr Bernd van Linder, Chief Executive Officer of the Commercial Bank of Dubai, the presenting sponsor of the Forum, stated, "Commercial Bank of Dubai is proud to support the UAE's sustainability ambitions through our participation in the Future Sustainability Forum 2024 as Presenting Sponsor. Our proactive approach in addressing environmental challenges, exemplified by the successful issuance of CBD's inaugural green bond, demonstrates our alignment with global environmental goals."The Forum will address critical sustainability issues across eight core pillars spanning different industries including banking and finance, construction, renewable and future energy, transportation and mobility, manufacturing and production, recycling and waste management, sustainable technology, and agriculture and food production.In addition to the packed conference agenda that will feature over 100 sustainability and climate action expert speakers, the Forum will bring together the most innovative solutions and service providers from across the global sustainability landscape through the Climate Action & Renewable Energy Expo (CARE).Government entities in the UAE have spearheaded a range of comprehensive sustainability programmes in the pursuit of a net-zero future. Initiatives such as the Dubai Clean Energy Strategy 2050, the UAE Net Zero 2050 strategic initiative, and the UAE Vision 2070, emphasise on a commitment to renewable energy adoption, water conservation, waste management, and sustainable urban development.For more information and to register, please visit the Future Sustainability Forum website.About Dubai International Financial CentreDubai International Financial Centre (DIFC) is one of the world’s most advanced financial centres, and the leading financial hub for the Middle East, Africa, and South Asia (MEASA), which comprises 77 countries with an approximate population of 3.7bn and an estimated GDP of USD 10.5trn.With a 20-year track record of facilitating trade and investment flows across the MEASA region, the Centre connects these fast-growing markets with the economies of Asia, Europe, and the Americas through Dubai. DIFC is home to an internationally recognised, independent regulator and a proven judicial system with an English common law framework, as well as the region’s largest financial ecosystem of 43,800 professionals working across over 6,150 active registered companies – making up the largest and most diverse pool of industry talent in the region. The Centre’s vision is to drive the future of finance through cutting-edge technology, innovation, and partnerships. Today, it is the global future of finance and innovation hub offering one of the region’s most comprehensive FinTech and venture capital environments, including cost-effective licensing solutions, fit-for-purpose regulation, innovative accelerator programmes, and funding for growth-stage start-ups.  Comprising a variety of world-renowned retail and dining venues, a dynamic art and culture scene, residential apartments, hotels, and public spaces, DIFC continues to be one of Dubai’s most sought-after business and lifestyle destinations. For further information, please visit our website: difc.ae, or follow us on LinkedIn and X @DIFC.For media enquiries, please contact:Nivine William | Nisha CelinaBurson | bursonglobal.comnivine.william@bursonglobal.com | nisha.celina@bursonglobal.com Rasha Mezher | Dubai International Financial Centre Authority Manager, Marketing & Corporate CommunicationsRasha.Mezher@difc.ae Hussain AlZaabi | Dubai International Financial Centre AuthorityManager, DIFC Innovation Hubhussain.alzaabi@difc.ae Shadi DawiDirector - PR & Media+971 55 498 4989shadi@tresconglobal.com  Copyright 2024 ACN Newswire via SeaPRwire.com.

僑雄國際否認媒體操縱股價質疑 稱價格波動是市場對公司未來預期反應

香港, 2024年10月25日 - (亞太商訊 via SeaPRwire.com) - 針對公司近日股價持續上漲,引發媒體質疑涉嫌操縱股價的報導、僑雄國際(00381.HK)今日盤後發佈公告稱,經公司董事會作出一切合理查詢後所知、所悉及所信,董事會堅決否認媒體報導中包含的猜測,並認為報導事項不准確且具有誤導性。僑雄國際在公告中進一步指出,公司已經諮詢其法律顧問,將會作出進一步行動。此外公司向負責傳播誤導性及惡意陳述,惡意沽空從而獲益的有關實體及╱或相關個人及任何人,導致的損害或其他補償,保留採取法律行動之權利。10月22日,有媒體發佈題為《16個交易日翻了近30倍,僑雄國際(00381)全靠兩個"經紀商"雄起?》,指出截至10月21日,中國北方證券和長橋證券兩個經紀商近20個交易日分別淨買入了0.92億股和0.27億股,持股比例分別為14.02%及3.42%,而其他經紀商僅有少量買入,由此質疑公司股價存在被操縱的嫌疑。僑雄國際執行董事兼聯席主席李立中對媒體回應稱,價格的波動是市場對公司未來預期的反應,是正常的市場行為。首先,乘著近期港股的升浪,很多公司股票都有明顯的升幅。加上公司近來管理層的變動,委任了有豐富資歷以及管理經驗的董事,這些可被股東看作利好消息,公司股價上漲表示股東對公司前景樂觀。二零二四年十月四日,僑雄國際委任李立中為執行董事兼聯席主席。李立中長期從事人工智慧、元宇宙、智聯網路、區塊鏈科學研究,這些領域的研究成果不僅推動了科技進步,而且為人類的生活帶來了巨大的改變。其工作成果向世界展示了中國科學家的智慧和實力,也為中國在科技領域的發展做出了重要貢獻。僑雄國際表示,國家「十四五」規劃中提出迎接數字時代,啟動數據要素潛能,推進網絡強國建設,加快建設數字經濟、數字社會、數字政府,以數字化轉型整體驅動生產方式、生活方式和治理方式變革。基於「十四五」規劃所帶來的數字化新浪潮,各行各業將獲得更多發展機遇,面對中國社會經濟發展新階段、新特徵,公司未來將專注於深化現有業務開發及運營,向數字媒體經銷等方向穩定發展,豐富業務的多元化結構,使得公司更加穩步向前。僑雄國際在公告中表示,董事會經作出在相關情況下有關公司的合理查詢後,董事會確認,其並不知悉導致價格或成交量波動的任何原因,或任何必須公佈以避免公司證券出現虛假市場的資料。李立中強調,該報導僅憑市場交易券商名字片面的指責懷疑公司操縱市場,期間並未與上市公司做任何的溝通與確認,是典型惡意沽空的犯罪行為。公司會對其新聞前惡意做空行為和新聞後操縱市場行為發出律師函和訴訟,以維護廣大投資者權益。前述媒體報導稱,"僑雄國際基本面並不好,公司主要從事玩具及禮品製造及銷售、天然資源勘探、水 果種植、休閒及文化及中草藥多種業務,業務表現平淡,業績收入已經連續兩個半年度下行,且盈利能力持續下降。今年該公司業務模式並未有重大變化,唯一變化是在10月10日,擬將公司名稱更名為權識國際集團(中文名稱)。"僑雄國際近期發佈公告,擬將公司名稱更改為"AOM International Group Company Limited",並採用"權識國際集團股份有限公司"作為其第二中文名稱。據悉,集團的業務有六大可呈報分類,由於各業務均有不同的經濟特徵,因此各業務被分開管理。對此李立中表示,僑雄國際更名為權識國際。未來會通過相關專利技術對公司各板塊業務做全方位的數位經濟轉型,通過生產資料的標識化,為公司的各個板塊注入新的價值與活力。因此引發股價上漲和投資者購買屬於正常市場現象。李立中指出,目前僑雄國際的資金狀況非常健康,公司管理層對公司發展的前景保持絕對的樂觀態度,會考慮在未來繼續增持公司股票,以帶給市場及公司股東信心,穩定因為不實報道,故意抹黑而影響的公司股價。關於後續的業務安排,公司會按照上市公司管理要求走合規的業務流程正常公告披露。公司謹提醒公司股東及潛在投資者,關注公司於聯交所網站(http://www.hkexnews.hk/index.htm) 。 Copyright 2024 亞太商訊 via SeaPRwire.com.

君聯投資企業地平線在香港聯交所成功上市

香港, 2024年10月25日 - (亞太商訊 via SeaPRwire.com) - 據君聯資本微信公號報道稱,10月24日,聯想控股(3396.HK)旗下君聯資本所投智駕科技企業地平線(9660.HK)在香港聯交所成功上市,地平線擬全球發行1,355,106,600股股份,其中香港公開發售135,511,200股,佔約10%;國際配售1,219,595,400股,佔約90%,另有超額配股權15%。截至發稿,地平線每股5.45港元,上市首日上漲36.59%,市值超過710億港元。這標誌著地平線作為一家智能駕駛解決方案的鏈主型領軍企業,開啟了全新「征程」。地平線是市場領先的乘用車高級輔助駕駛(ADAS)和高階智能駕駛(AD)解決方案供應商,成立於2015年7月,創始人余凱博士,本碩畢業於南京大學電子科學與工程學系,長期在計算機工程領域深耕。地平線的產品包括征程系列芯片,這些芯片被廣泛應用於智能駕駛領域,包括高級輔助駕駛(ADAS)和高階智能駕駛(AD)解決方案。依託已大規模部署的前裝量產解決方案,地平線已成為智能汽車轉型及商業化的關鍵推動者。灼識咨詢報告顯示,自2021年起,按解決方案總裝機量計算,地平線是首家且每年均為最大的提供前裝量產的高級輔助駕駛和高階智能駕駛解決方案的中國公司。地平線擁有龐大的全球客戶群,包括行業領先的OEM(原始設備製造商)和國產汽車製造一級供應商,公司提供的解決方案整合了算法、專用軟件和處理硬件,旨在提高駕駛安全性和乘客體驗。截至2024年9月底,地平線累計定點車型290款、累計量產車型152款。目前,地平線征程家族車載智能計算方案出貨量累計已突破600萬套。2024年上半年,地平線營業收入9.3億元,同比增長超150%。君聯資本於2021年3月投資地平線,投資時地平線生產的智能駕駛芯片在各車企剛剛開始投入應用,投資後,公司產品持續迭代,研發生產了國內首款可量產的百TOPs級車載大算力智能駕駛芯片——征程5系列產品並形成批量生產應用,公司最新研發的征程6也持續量產並在各大車企銷售。君聯一路陪伴公司成長,在智能駕駛產業鏈上下游資源引薦等方面給予了公司支持和幫助。君聯資本對地平線成功上市表示祝賀,隨著汽車「智能化、網聯化」的驅動,智能駕駛芯片已成為智能汽車智能駕駛的核心,地平線是行業內稀缺的有能力將算力在芯片產品上落地的企業,余凱博士帶領的團隊具有遠大格局和前瞻性,有較強的商業落地能力和豐富的企業管理經驗,隨著我國智能汽車行業的持續增長,君聯資本相信,上市後的地平線在智能駕駛領域將會持續拓展更廣闊的市場和業務鏈條。智能駕駛技術是新質生產力的典型代表。君聯長期實踐科創投資,在人工智能、碳中和、半導體、數字經濟、生物醫藥等國家戰略性產業上密集投資,深入理解和融入國家創新型企業培育體系,持續推動所投企業面向解決「卡脖子」問題的重大創新方向,補鏈強鏈。君聯資本作為聯控旗下專注于早期創業投資以及成長期私募股權投資的專業投資機構,在二十多年的發展歷程中,遵循國際通行標準,經歷了多支基金的完整管理週期,創造了可持續的基金業績。據其官網顯示,已累計投資600多家企業,其中有113家在全球不同資本市場IPO退出,近100家通過並購退出。其所投企業中,既包括科大訊飛、寧德時代、藥明康得、康龍化成這樣的頂尖企業,也有大量的國家級專精特新小巨人和製造業單項冠軍,構建了豐富的產業資源。 Copyright 2024 亞太商訊 via SeaPRwire.com.

Formerra and H.B. Fuller Announce Strategic Partnership to Drive Growth in Advanced Bonding Solutions

ROMEOVILLE, IL, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - Formerra, a leader in performance materials distribution, announced today that it has been named a Platinum Partner in H.B. Fuller's Channel Partnership Program. This partnership positions the company to lead distribution efforts for H.B. Fuller's Cilbond® adhesives across North America and builds on over a decade of distribution success at Suministro de Especialidades ("Suministro"), a leading Mexican distributor acquired by Formerra in late 2023.Cilbond serves a variety of industries, including automotive applications that require rubber-to-metal bonds, such as suspension bushings, engine mounts, and anti-vibration systems.Suministro has played a pivotal role in advancing applications for Cilbond throughout Mexico. Formerra will complement this established relationship to deliver H.B. Fuller's innovative Cilbond bonding agents to the broader North American market, offering a unique combination of technical expertise, sustainable solutions, and customer support. Combined with Formerra's expansive reach, this will enable support for manufacturers in streamlining their processes and improving production.The Cilbond product line offers specialized bonding agents that cater to Power Grid, Transportation, Industrial, Oil, Gas & Mining industries, and more.Cilbond provides a variety of coating systems, ranging from the conventional two-coat system, known for its durability and bonding strength, to a cutting-edge one-coat system. Cilbond's one-coat options deliver a streamlined solution, saving both time and cost for customers. With additional water-based options, Cilbond aligns with the growing demand for more sustainable products, enabling manufacturers to reduce their potential environmental impact without sacrificing performance."Our new relationship with Formerra marks a significant step forward in our North American growth strategy," said Tim O'Neil, Managing Director at H.B. Fuller. "By combining Formerra's strong portfolio of complementary materials and technical expertise with our innovative technology, we're able to provide advanced solutions that meet the evolving needs of manufacturing customers. Together, we're well-positioned to help them increase efficiency, reduce costs, and meet sustainability goals.""We're confident that our deep technical capabilities, combined with Suministro's proven track record, position us to maximize the potential of this partnership for both parties," said Doug Zupan, Vice President of Operations at Formerra. "In bringing H.B. Fuller's innovative bonding solutions to the rest of North America, we intend to deliver exceptional value and support to our customers."About HB FullerAs the largest pureplay adhesives company in the world, H.B. Fuller's (NYSE:FUL) innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2023 revenue of $3.5 billion, our mission to Connect What Matters is brought to life by more than 7,000 global team members who collaborate with customers across more than 30 market segments in over 140 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets. Learn more at www.hbfuller.com.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.Contact InformationJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2024 ACN Newswire via SeaPRwire.com.

GMG Reaches Major Milestones in THERMAL-XR(R) Test Work

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - October 23, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG" or the "Company") is pleased to provide a technical update on the commercialisation progress of THERMAL-XR® Powered by GMG Graphene.PRODUCT TECHNICAL UPDATETHERMAL-XR® has now successfully passed 15,000 hours for corrosion protection under a salt sea spray industry standard test (ASTM B117) in a third-party laboratory in the US as seen in Figure 1. The Company believes that THERMAL-XR® is one of the longest lasting corrosion protection coatings available on the market. The testing will continue, and further reports will be updated by the Company.Figure 1: THERMAL-XR® Coating Corrosion Test Results After 15,000 Salt Sea Spray Hours (ATM B117)To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_ecd3ffa9c41478c4_001full.jpgGMG can now accurately model and calculate the heat transfer rate expected from THERMAL-XR®, as compared to bare (uncoated) Aluminium, within 1% of actual results. This was reviewed and verified by the University of Queensland.Figure 2 shows the simulation model used to calculate the heat transfer coefficients of bare aluminium, versus THERMAL-XR® coated aluminium, on the test rig that GMG built and operated to obtain the experimental data. The test was conducted at a temperature of approximately 100 degree Celsius.Figure 2: Estimation of Heat Transfer of THERMAL-XR® coated aluminium versus bare aluminiumTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_gmg_figure2.jpgThrough this work, as shown in Figure 3, the Company has demonstrated that THERMAL-XR® provides approximately 8.6 times more radiative heat transfer than bare aluminium, due to its thermal radiation (passing of heat in wave forms) capabilities. THERMAL-XR® has been calculated to provide 8.15 W/m2K (Watts per metre squared Kelvin degrees), or approximately 1.44 Btu/hr ft2 F (British thermal units per hour foot squared Fahrenheit degrees), of heat transfer when applied properly on top of bare aluminium, as compared to 0.95 W/m2K or 0.17 Btu/hr ft2 for bare aluminium.Figure 3: Thermal Radiation calculations of THERMAL-XR® coated aluminium versus bare aluminiumTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_ecd3ffa9c41478c4_004full.jpgFigure 4 shows THERMAL-XR® increases the overall heat transfer coefficient by 2.2 times more than bare aluminium, from 6.0 W/m2K up to 13.2 W/m2K because of the increase in the thermal radiation from the THERMAL-XR® coating. This was conducted at a temperature of approximately 100 degree Celsius for a 100mm diameter flat plate.Thermal Coefficient (W/m2K)Bare AluminiumTHERMAL-XR® Coated AluminiumThermal Radiation0.958.15Natural Convection (Air Cooling)5.085.08Total Heat Transfer6.013.2(2.2 Times)Figure 4: NATURAL Convection Overall Thermal Coefficient of THERMAL-XR® versus bare aluminiumFigure 5 shows that THERMAL-XR® provides approximately 27% more heat transfer when including FORCED convection (fan air cooling) over bare aluminium from 26.6 W/m2K up to 33.8 W/m2K because of the increase in the thermal radiation from the THERMAL-XR® coating. This was conducted at a temperature of approximately 100 degree Celsius and with modelling of the air speed at an approximate 5 metres/second.Thermal Coefficient (W/m2K)Bare AluminiumTHERMAL-XR® Coated AluminiumThermal Radiation0.958.15Forced Convection (Fan Air Cooling)25.7125.71Total Heat Transfer26.633.8(27% Increase)Figure 5: FORCED Convection Cooling Overall Thermal Coefficient of THERMAL-XR® versus bare aluminiumGMG's Managing Director and CEO, Craig Nicol, commented: "GMG continues to make good progress in testing THERMAL-XR® for corrosion protection and heat transfer - our increased understanding of the heat rejection rate of the product allows us to better recognise how it can be of potential value for various types of products in various applications and markets."GMG's Chairman and Director, Jack Perkowski, commented: "THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into so many industries - so it is great to see the progress."About THERMAL-XR® powered by GMG Graphene:THERMAL-XR® COATING SYSTEM is a unique method of improving the heat conductivity of corroded heat exchange surfaces and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces increasing service life, while improving and rebuilding the lost corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.THERMAL-XR RESTORE® is powered by GMG Graphene. PATENT PENDINGAbout GMG www.graphenemg.comGMG is a clean-technology company which seeks to offer energy saving and energy storage solutions, enabled by graphene, including that manufactured in-house via a proprietary production process. GMG has developed a proprietary production process to decompose natural gas (i.e. methane) into its elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating), lubricants and fluids.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries").GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, that the Company will continue testing THERMAL-XR® and provide further updates, that increased understanding of THERMAL-XR® will allow the Company to better recognize how it can add value in various types of products in various applications and markets, and that THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into many industries. Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the Company will continue to test THERMAL-XR® and provide updates, that an increased understanding of THERMAL-XR® will enable the Company to better identify how THERMAL-XR® can add value for various products in various applications and markets, and that THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into many industries. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that the Company will not continue testing THERMAL-XR®, that the Company will not provide further updates regarding THERMAL-XR®, that a better understanding of THERMAL-XR® will not allow the Company to better recognize how it can add value in various types of products in various applications and markets, that THERMAL-XR® testing in corrosion protection and heat transfer will not be highly translatable into many industries, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227525 Copyright 2024 ACN Newswire via SeaPRwire.com.

Stable S&P rating supports Fosun’s globalization and innovation

HONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - HK equity market experienced snap adjustment rally in September, and is now entering stock picking phase before new round of catalyst arrives. Now is the period when investors explore resilient names whose fundamentals is robust enough to weather market turbulence. Fosun International (00656) fits into this category, with its continuous efforts on innovation and globalization, combined with solid delivery on financial result and attractive valuation.Fosun International is one of the few leading enterprises rooted in China with global operational capabilities. Since its establishment in 1992, Fosun International has built an industrial presence in more than 35 countries and regions worldwide, continually enhancing its global operational capabilities. It has now become a global innovation-driven consumer group.Enhancing innovation capabilities while delivering robust global operational capabilitiesOver past decades, Fosun has been enhancing and deepening its globalization capabilities via launching new products and advancing its international operation.Take pharmaceutical products for example, the biosimilar HANQUYOU has pioneered the international market expansion for Fosun. With licensing agreements covering approximately 100 countries and regions and marketing approvals in 48 countries and regions, HANQUYOU has become the China-developed biosimilar with the most marketing approvals.Thanks to the overseas expansion of biosimilars, Fosun has not only established its reputation internationally, but has also gained experience in the globalization of first-in-class drugs. HANZISHUANG, the world's first anti-PD-1 monoclonal antibody approved for the first-line treatment of small cell lung cancer (SCLC) independently developed by Shanghai Henlius, is an example of success. Fosun's overseas expansion of biopharmaceutical has resulted in the advancement of both first-in-class drugs and biosimilars. In 2023, Shanghai Henlius became the first first-in-class pharmaceutical company among its peers to achieve profitability through product sales.In terms of operations, Fosun International focuses on organization evolution and global resource integration. By leveraging regional advantages, it establishes a profound industrial presence and localized operations to continuously benefit its industries and brands.For example, in the tourism sector, Fosun Tourism Group (FTG) has achieved remarkable growth through its unique asset-light operating model, global presence and global operations. FTG's subsidiary Club Med, which operates 67 resorts worldwide, achieved a record-high business volume of RMB8.89 billion in the first half of 2024, representing a year-on-year increase of 10.3%. Its business in the Europe, Middle East and Africa (EMEA) region and the Americas continued to grow, while its business in Asia-Pacific region recovered significantly. In May 2024, Club Med signed an agreement in Oman for the launch of its first resort in the Middle East.Notably, there are very few domestic tourism companies that adopt an asset-light operating model and are equipped with global operational capabilities, making FTG a benchmark for the development of China's tourism industry. In addition, Fosun International continues to drive innovation and optimization in the consumption and insurance sectors, making positive impact on China's economic growth and industrial upgrades.As Fosun International enhances its focus on its "products + operations", its globalization capabilities are gradually bearing fruit, while its innovation capabilities are further developing. This approach has effectively strengthened its advantages in core industries such as tourism, consumption, pharmaceuticals, and insurance, garnering market optimism.S&P affirms Fosun International's "stable" rating outlook, noting that creditworthiness remains steadyRecently, Fosun International received further recognition in the international rating agencies. On 21 October, S&P released a report acknowledging Fosun's successful asset divestment and debt reduction efforts, assigning it a stable rating outlook.Specifically, S&P acknowledges the improvement of Fosun's liability structure, noting that bank loans now account for 73% of the holding company's debts, up from 46% in mid-2022. Fosun International completed a USD888 million offshore syndicate in September 2024, reflecting an increase in both bank participation and size compared to the syndicate due in May. S&P regards this as a clear evidence of recovery in offshore bank refinancing channels.The smooth access to financing channels reflects the confidence of domestic and international financial institutions in Fosun's financial position and business strategy. This not only reduces Fosun's reliance on public market financing but also allows for better support of liquidity management and greater flexibility to manage the pace of future asset divestment. S&P expects Fosun's asset recycling could continue to drive further debt reduction.The positive evaluation from S&P affirms Fosun International's strong execution of its globalization and innovation capabilities. Over the past two years, the remarkable improvement in its balance sheet and enhanced financial resilience have been evident. Additionally, this endorsement reinforces the company's investment value.Overall, as the outlook for the Chinese economy improves, especially with the implementation of key policy initiatives, the Hong Kong stock market holds significant growth potential. Thanks to its global presence, integrated innovation, and asset-light operating strategy, Fosun International is enhancing performance certainty and strengthening its financial resilience against risks. As its global operations continue to expand, industry-leading advantages strengthen, and the benefits of technology innovation accelerate, Fosun is poised to capitalize on the next wave of growth in the Hong Kong stock market. Copyright 2024 ACN Newswire via SeaPRwire.com.

Asian Actuarial Conference 2024 Kicks Off in Hong Kong to Great Acclaims

- HKSAR Under Secretary for Financial Services and the Treasury Joseph Chan honoured the event by delivering opening remarks- Returning after six years, the Asian Actuarial Conference 2024 receives overwhelming support from over 1,000 international professionals- Expertise of actuaries can reinforce Hong Kong’s capability as a premier risk management centre, therefore contribute to the resilience and sustainable growth of the cityHONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - The three-day Asian Actuarial Conference 2024 (AAC 2024) organised by the Actuarial Society of Hong Kong (ASHK), commenced today at the Ocean Park Marriott Hotel. This year's conference, themed “Exploring the Future of Insurance and Beyond: Innovation, International Hubs, and Hong Kong,” has more than 100 internationally renowned experts from diverse industries as speakers and panellists, and close to 1,000 participants including actuarial professionals, executives, and thought leaders from across Asia and beyond, making it a significant gathering in the actuarial community.Mr. Joseph Chan, Under Secretary for Financial Services and the Treasury of the HKSAR, officiated the opening ceremony together with Mr. Timothy Wong, President of the Actuarial Society of Hong Kong, Mr. Stephen Yiu, Chairman of the Insurance Authority, and Ms. Daisy Ning, Head Life & Health APAC ex China of Swiss Re.Timothy Wong, President of the ASHK, said, “We are delighted to have top business leaders in the region coming to Hong Kong to join AAC 2024, returning to the city after six years. Apart from allowing us, actuaries and insurers, to gain valuable insights on the evolving landscape of the professions, the Conference is also a vital platform for us to connect with practitioners in other professions that have wide-reaching implications for the future of ours. With the market changing so rapidly, it is essential for actuaries to stay abreast of latest industry developments and to unlock the vast potential of actuarial science to the benefit of diverse fields. Together, we are paving the way for growth of the actuary profession in Hong Kong.”Alongside technologies advancing at ever faster speed and with business opportunities of all kinds emerging in the Greater Bay Area, financial markets in the region have also become more complex and sophisticated. More companies are recognising the importance of financial planning and the need to effectively manage risks. Actuaries, equipped with a unique blend of analytical and business skills, are adept at helping businesses address diverse financial and social challenges. By developing models to assess the current financial implications of uncertain future events, they enable companies to make scientific and rational decisions.Also, taking into account the risk-based capital (RBC) regime for the Hong Kong insurance industry introduced on July 1 this year, plus the 2024 Policy Address just delivered by the Chief Executive of the HKSAR outlining ways to enhance development of the insurance sector, attract large enterprises to establish captive insurers in Hong Kong, and strengthen Hong Kong's position as a global risk management centre, actuaries are going to be in great demand in the near future.The government intends to examine capital requirements of and drive infrastructure investment, and enrich insurance companies' asset allocation for risk diversification, which are expertise areas of the actuarial profession, showing that actuaries have a  pivotal role to play in ensuring  the resilience and sustainable growth of the city.Simon Lam, Co-Chairperson Organising Committee Asian Actuarial Conference 2024  concluded, “As of December 2023, ASHK has a total of 1,293 members. With polices and regulations in its favour,  ASHK, as the leading professional body for actuaries in Hong Kong, is ready to nurture more talent for the profession to meet the rising demand.”Day Two and Three of the AAC 2024 will explore important themes such as growth in emerging Asia, Hong Kong as an international hub, regulation, artificial intelligence, blockchain, ESG, professionalism, and more. The conference will conclude on Friday with excursions for delegates to visit the Greater Bay Area, Hong Kong Cyberport, Hong Kong Science Park, and the Palace Museum.For more information please visit: https://aac2024.hk/index About the Actuarial Society of Hong KongThe professional body for actuaries in Hong Kong was first formed in 1968 as the Actuarial Association of Hong Kong, its successor, the Actuarial Society of Hong Kong (ASHK) was later incorporated in 1994. It is governed by an elected Council with a President and 14 other Council Members. Fellow Members are entitled to use the FASHK designation which is a requirement for all Insurance Authority applications for Long-Term Appointed Actuaries and General Insurance Certifying Actuaries.The ASHK sets the Professional Standards outlined in the Insurance (Actuaries’ Standards) Rules (Cap. 41, section 129(1)) and the Actuarial Guidance Notes outlined in the various Insurance Authority Guidelines for the actuarial profession in Hong Kong. www.actuaries.org.hk About the Asian Actuarial ConferenceStarting from 2013, the Asian Actuarial Conference is usually a biennial event organised by an Asian Actuarial Association member organisation on a rotational basis. It has become the most important actuarial event in Asia. To date, the Asian Actuarial Association is made up of 12 actuarial organisations with close to 25,000 members. These member organisations come from* Australia, China, Chinese Taipei, Hong Kong, India, Indonesia, Japan, Malaysia, Singapore, South Korea,  Thailand, and the Philippines.*In alphabetical order.From Left to Right:Mr. Simon Lam, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Ms. Daisy Ning, Head Life & Health APAC ex China of Swiss ReMr. Stephen Yiu, Chairman of the Insurance AuthorityMr.Timothy Wong, President of the Actuarial Society of Hong KongMr. Joseph Chan, HKSAR Under Secretary for Financial Services and the TreasuryMr. Clement Cheung, CEO of the Insurance AuthorityMr. Alex Wong, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Mr. Billy Wong, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Mr. Joseph Chan, Under Secretary for Financial Services and the Treasury of the HKSAR, honoured the event by delivering opening remarksMr. Timothy Wong, President of the Actuarial Society of Hong Kong, welcomes over 1,000 professionals from across Asia andbeyond to join this significant actuarial conference  Copyright 2024 ACN Newswire via SeaPRwire.com.

Hong Kong International Optical Fair to open in November

- Over 700 exhibitors from 17 countries and regions to participate from 6-8 November at the Hong Kong Convention and Exhibition Centre- Exhibition reflects four prominent market trends: technology, lifestyle, functionality and sustainability- Concurrent Hong Kong International Optometric Symposium to explore latest breakthroughs in myopia control and prevention- Finalists of the 24th Hong Kong Eyewear Design Competition to be unveiledHONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - The 32nd Hong Kong International Optical Fair, organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Optical Manufacturers Association (HKOMA), will take place on 6-8 November at the Hong Kong Convention and Exhibition Centre. Under the theme of Seeing is Believing, the Fair features innovative and state-of-the-art eyewear designs and products, bringing together industry players to facilitate new business opportunities.Sophia Chong, Acting Executive Director of the HKTDC emphasised: "This year’s Hong Kong International Optical Fair, a long-standing industry highlight for over 30 years, is more international than ever, attracting more than 700 exhibitors from 17 countries and regions. The fair reflects the dynamic evolution in eyewear design and technology. Exhibitors worldwide are aligning their products with key trends in technology, lifestyle, functionality and sustainability to capture expanded market opportunities. This exhibition, which is truly a feast for the eyes, demonstrates Hong Kong's advantages as an international trade and procurement centre."Hong Kong ranks as the world's third-largest exporter of eyewear and frames. The total export value of Hong Kong's eyewear, lenses and frames is estimated to have reached HK$19.9 billion in 2023, signalling substantial growth. The smart eyewear sector has emerged as an industry focal point, with the global market exceeding HK$40 billion in 2023 and projected to surpass HK$100 billion by 2029.Exhibitors from around the globe, including Europe and Americas, such as France, Germany, the United Kingdom and the United States, as well as Asia such as Japan, Korea, Malaysia, Singapore, Taiwan, and Türkiye in the Middle East, and more, will present their latest offerings at the fair. Prominent Hong Kong brands will also have a significant presence.This year’s Optical Fair will feature a number of group pavilions, including Mainland China, Japan, Korea and Taiwan, as well as the Visionaries of Style and HKOMA Pavilion; along with pavilions from cities in Mainland China, including Danyang in Jiangsu, Jiaojiang in Zhejiang, Shenzhen in Guangdong and Yingtan in Jiangxi.The Brand Name Gallery, the focal point of the Fair, will showcase over 200 renowned global brands. Other zones will present a broad spectrum of eyewear products, including Smart Eyewear, Contact Lenses & Accessories, Designer Café pavilion, Sporting & Professional Eyewear, Kids Eyewear & Reading Glasses, Lenses, Frames & Parts, Eyewear Accessories, Diagnostic Instruments, as well as Optometric Instruments, Equipment & Machinery.The 22nd Hong Kong International Optometric Symposium will be held on 7 November. Jointly organised by the HKTDC, the Hong Kong Optometric Association and The Hong Kong Polytechnic University, this year's symposium will focus on myopia control and prevention. Scholars from Mainland China, Hong Kong, Australia, and Germany will lead discussions with industry professionals. The symposium is a pre-approved CPD Programme recognised by the Optometrists Board and attendees will receive a Certificate of Attendance. The Fair will also offer talks and seminars on smart eyewear, functional eyewear, sustainability and other advancements in the eyewear industry.To foster Hong Kong’s creativity and innovation, the HKTDC and HKOMA will run the 24th Hong Kong Eyewear Design Competition under the theme of Be Bold. Results will be announced during the Hong Kong International Optical Fair. Winning and final entries will be on display at The Forum, Hall 1D during the fair period to showcase Hong Kong’s creativity to international buyers.Under the EXHIBITION+ hybrid model, exhibitors and buyers can meet online through the Click2Match business matching platform in addition to attending the physical fair until 15 November. Buyers can also use the Scan2Match feature of the HKTDC Marketplace App to scan the QR codes of exhibitors and view product materials, bookmark favourites, browse product information and floor plans, as well as engage with exhibitors before and after the fairs to continue their sourcing journey.Featured ProductsExhibitors at the forefront of the industry are unveiling an array of innovative eyewear products in line with technology, lifestyle, functionality and sustainability trends. Some of the highlighted products are:TechnologySolos AirGo Vision – Smart EyewearEquipped with a camera, AirGo Vision is the world's first smart eyewear with ChatGPT-4 functionality, and provides instant responses to what you see Solos Technology LimitedProduct Zone: Visionaries of Style Booth: GH-B26Reform EyewearReform features a new patented flexible frame technology that seamlessly adapts to any frame shape, size, colour or material, suitable for both prescription and sunglasses. This innovation offers endless possibilities for eyewear design, while ensuring safety and comfort.Icare (Hong Kong) Company LimitedProduct Zone: Hong Kong Optical Manufacturers Association Pavilion Booth: 1E-C08LifestyleFashion-Forward Yagioka EyewearThe local design brand Big Horn has launched the Yagioka eyewear line, featuring a modern and refined design that is perfect for fashion-forward people. This eyewear design was a finalist for the USA Accessories Council's Design Excellence Awards 2024.The Panda eyewear series draws inspiration for its colours and shapes from the beloved animal. Crafted with precision and made from high-quality biodegradable materials, it combines functionality with aesthetic appeal.Winky International LimitedProduct Zone: Brand Name GalleryBooth: GH-R03Rosie Allan – A Design for Both Parents and ChildrenEstablished in 2020, Rosie Allan transcends being just a brand; it celebrates family bonds and unforgettable moments. Specialising in 100% handcrafted acetate sunglasses, the matching parent-child collection symbolises love and togetherness.Rosie Allan Pty LtdProduct Zone: Brand Name GalleryBooth: GH-D07Luxury Jewellery-inspired Handcrafted EyewearThis Japanese brand merges high-end jewellery design with eyewear, utilising premium materials, such as 18K gold and natural diamonds. Each pair is meticulously handcrafted with a commitment to artisanal craftsmanship and is specifically designed for Asian facial features, exuding elegance.Inon Co. Ltd.Product Zone: Japan PavilionBooth:  GH-B12Functionality:Nano Vista Children's Sports EyewearCrafted exclusively for kids and young athletes, Nano Vista - a Spanish brand - offers eyewear designed for outdoor activities. It is internationally recognised for safety, meets European EN166:2001 standards and is endorsed by top sports federations.Opticon LtdProduct Zone: Brand Name GalleryBooth: GH-C06Sustainability:Sustainable Eyewear Frame SolutionThe eyewear frames are made from BioCell material. BioCell is a cellulose acetate derived from cotton or wood pulp, certified as biodegradable according to ISO 14855 standards. It contains no industry-standard plasticisers and is compatible with polycarbonate lenses.Eleung LimitedProduct Zone: Hong Kong Optical Manufacturers Association PavilionBooth: 1E-D14Eco-Friendly Nylon and PC LensesEco-friendly nylon and polycarbonate (PC) lenses are produced using sustainable materials, reducing carbon emissions during the manufacturing process. They feature high abrasion and scratch resistance and have received multiple certifications. Even in low-temperature conditions, they maintain hardness and toughness, providing excellent clarity and optical transmission performance.Mellan LimitedProduct Zone: Frames & PartsBooth: 1E-C28 Last year’s Hong Kong International Optical Fair was a great successPhoto download: https://bit.ly/3NzTZIrWebsites:The 32nd Hong Kong International Optical Fair:https://www.hktdc.com/event/hkopticalfair/enEvent Details of the Hong Kong International Optical Fair: https://www.hktdc.com/event/hkopticalfair/en/intelligence-hub    The 22nd Hong Kong International Optometric Symposium: https://www.hktdc.com/event/hkopticalfair/en/the-22nd-hong-kong-international-optometric-symposiumThe HKTDC’s Media Room: http://mediaroom.hktdc.com/enFair Details (Physical)Date:6 – 8 November (Wednesday to Friday)Time:(6 to 7 November) 9:30am – 6:30pm(8 November) 9:30am – 5:00pmVenue:Hong Kong Convention and Exhibition CentreAdmission:For trade visitors aged 18 or above only. Onsite Registration Fee: HK$100 per person (free for e-Badge registration and pre-registered buyers)Click2Match – Smart Business Matching PlatformDate:30 October – 15 NovemberMedia enquiriesPlease contact the HKTDC’s Communications and Public Affairs Department:Johnny TsuiTel: (852) 2584 4395johnny.cy.tsui@hktdc.orgSharon HaTel: (852) 2584 4575sharon.mt.ha@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2024 ACN Newswire via SeaPRwire.com.

標普穩定評級支持復星全球化及創新發展

香港, 2024年10月23日 - (亞太商訊 via SeaPRwire.com) - 在「普漲」之後,港股市場迎來在當前位置的震盪消化,以結構性行情為主,等待更多催化劑。在此背景下,投資者更要關注港股具有優勢的結構性機會,即便市場出現波動,也更具有韌性。比如,兼具創新能力和全球化能力,業績與估值持續兌現的復星國際(00656)值得高看一線。復星國際是少有的植根中國、能在全球佈局營運的龍頭企業。自1992年創立以來,復星國際已在全球超35個國家和地區擁有產業佈局,全球化深度營運能力不斷提升,如今已成為一家創新驅動的全球家庭消費產業集團。創新能力持續深化,全球營運能力強兌現復星國際全球化能力的錘鍊,一方面來源於創新產品的持續輸出,另一方面則在於全球營運能力的不斷精進。產品方面,生物類似藥-漢曲優為復星國際的出海起到了「先鋒」的作用。漢曲優憑藉的對外授權覆蓋約100個國家和地區,在48個國家和地區獲批上市,成為獲批上市國家和地區最多的國產生物類似藥。有了生物類似藥的出海鋪路,不僅復宏漢霖在國際上打響名堂,還積累了創新藥全球化的經驗。復宏漢霖自主研發的全球首個獲批一線治療小細胞肺癌的抗PD-1單抗漢斯狀,便是重要的代表。至此,復星的生物藥出海,實現了創新藥、生物類似藥並駕齊驅的新局面。2023年復宏漢霖成為同行企業中第一個靠產品銷售盈利的創新藥企。營運方面,復星國際透過組織進化,整合全球資源,根據不同國家和地區的稟賦,實現深度產業佈局和屬地化經營,讓旗下產業、品牌不斷從中受益。比如旅遊領域,復星旅文以其獨特的輕資產營運模式、全球化佈局及全球化營運實現業績亮眼增長。復星旅文Club Med地中海俱樂部在全球營運67家度假村,2024年上半年營業額再創新高,達人民幣88.9億元,同比增長10.3%。其中,歐非中東及美洲區持續增長,亞太區復甦顯著。2024年5月,Club Med在阿曼簽約中東首個度假村。值得關注的是,在國內市場,同時具備輕資產模式與全球化營運能力的旅遊企業極為稀缺,復星旅文為中國旅遊業的發展樹立標竿。同時,在消費和保險等領域,復星國際也透過不斷創新和優化,為中國經濟的增長和產業升級做出了積極貢獻。隨著「產品+營運」的持續加碼,復星國際的全球化能力逐步兌現,創新能力持續深化。在旅遊、消費、醫藥、保險等核心產業賽道的優勢提升顯著,獲得市場廣泛看好。標普確認復星國際「穩定」評級,信用指標穩中向好近期,復星國際在國際投資市場再獲肯定。10月21日,標普發佈報告,肯定復星國際資產處置降債的成績,並給予穩定展望。具體來看,標普認可復星國際負債結構的優化,銀行貸款在總負債中的佔比,從2022年中的46%,上升到目前的73%。2024年9月完成的境外銀團規模達到了8.88億美元,較再融資的5月到期銀團在銀行參與度以及金額均有所提升。標普認為這是復星在國際銀團融資環境本質性改善的最佳證明。暢通的融資管道背後反映出國內外金融機構對復星資金面和業務策略的信心,不僅進一步降低了復星對公開市場融資的依賴度,持續優化的債務結構也能更好地支持後續的流動性管理和更靈活地把握後續資產處置的進度。對此,標普預期復星集團非核心資產退出驅動降債的策略將繼續。標普的積極評價,一方面印證了復星國際在全球化能力與創新能力的強有力兌現,近兩年資產負債表的明顯修復、財務穩健性不斷增強;另一方面也為公司的投資價值提供了強有力的背書。綜上,隨著中國經濟預期轉好,尤其是相關重磅政策規劃落地,港股後市仍有較大發展空間。復星國際受益於全球化佈局、整合式創新及輕資產營運策略,業績確定性增加、財務穩健抗風險能力提升。後續隨著全球化業務持續增長、行業領先優勢不斷擴大,以及科技創新紅利加速兌現,有望乘著港股新一輪行情表現,率先開啟新的增長週期。 Copyright 2024 亞太商訊 via SeaPRwire.com.

2024年亞洲精算大會於香港隆重揭幕

- 香港特別行政區政府財經事務及庫務局副局長陳浩濂致開幕辭,令活動生色不少- 2024年亞洲精算大會六年後重臨香港,獲超過1,000名專業人士熱烈支持 - 精算師的專業知識可加強香港作為主要風險管理中心的能力,為提升其韌性及可持續發展作出貢獻香港, 2024年10月23日 - (亞太商訊 via SeaPRwire.com) - 由香港精算學會(ASHK)主辦為期三天的2024年亞洲精算大會今天假香港海洋公園萬豪酒店揭幕。今年大會以「探索保險業的未來及長遠發展:創新、國際樞紐與香港」為主題,邀請到來自不同行業逾百位國際知名的專家擔任演講嘉賓及專題討論成員,吸引來自亞洲及其他地區近1,000名精算專業人士、高管和思想領袖等參與,促成是次精算界盛會。香港特別行政區政府財經事務及庫務局副局長陳浩濂先生、香港精算學會會長黃光曦先生、保險業監管局主席姚建華先生,以及瑞士再保險亞太區壽險與健康險再保險業務負責人(中國除外)任曉薇女士一同主持開幕典禮。香港精算學會主席黃光曦表示:「我們很高興邀請到區內頂尖的商界領袖來港,參與六年後再度回歸香港的2024年亞洲精算大會。除了讓一眾精算師及保險公司獲取有關行業不斷變化的重要見解外,大會更是個重要的平台,把我們與對行業未來具深遠影響的其他專業人士聯繫起來。面對瞬息萬變的市場,精算師必須緊貼行業最新的發展動態,並釋放精算科學於各個領域的巨大潛力。各界攜手,一起為香港的精算專業發展鋪路。」隨著科技發展日新月異以及大灣區湧現出各種商機,區內的金融市場變得日益複雜。越來越多公司意識到財務規劃的重要及有效管理風險的必要。精算師獨有兼備分析和商業技能,擅長幫助企業應對各種金融和社會挑戰。透過開發模型評估未來不確定事件對當前財務的影響,藉以協助企業作出具科學理據的理性決策。此外,考慮到今年7月1日推出的香港保險業風險為本資本制度(RBC),以及香港特別行政區行政長官剛發表的《2024年施政報告》,其中提到促進保險業發展、吸引大型企業在港設立專屬的自保公司,以及鞏固香港作為全球風險管理中心的措施,可見市場對精算師的需求將在不久的將來逐步提升。此外,政府擬研究透過基建投資的資本要求豐富保險公司資產配置以助分散風險,亦屬精算的專業領域,反映精算師在確保香港的韌性和可持續發展方面發揮著關鍵作用。亞洲精算大會籌備委員會聯席主席林溢東總結:「截至2023年12月,香港精算學會共有1,293名會員。鑑於有利行業的政策和法規出台,作為香港領先的精算師專業團體,香港精算學會已準備好為行業培育更多人才,以滿足不斷增長的需求。」2024年亞洲精算大會第二天和第三天的議程將探討一些重要主題,例如新興亞洲的增長、香港作為國際樞紐、監管、人工智能、區塊鏈、環境、社會和管治(ESG)、專業精神等。大會將於星期五安排與會者以參觀大灣區、香港數碼港、香港科學園及香港故宮文化博物館作結。欲了解更多有關亞洲精算大會2024的詳情,請瀏覽:https://aac2024.hk/index 關於香港精算學會為香港精算師而設的專業團體 ─ Actuarial Association of Hong Kong,最初成立於 1968 年。其後,香港精算學會(ASHK)於1994 年成立並繼承前者。香港精算學會由選舉產生的委員會管理。委員會由一名主席和另外 14 名委員會成員組成。資深會員獲賦予使用「FASHK」名銜的權利,是所有保險業監管局對長期委任精算師和一般保險認證精算師的申請要求。香港精算學會制定了《保險業(精算師標準)規則》(第 41 章,第 129(1)條)中所述的專業標準,以及在不同保險業監管局指引中所述的精算實務指引,為香港的精算專業人士提供引導。 www.actuaries.org.hk 關於亞洲精算大會自 2013 年起,亞洲精算師協會的成員圑體一般會輪流籌辦每兩年一屆的亞洲精算大會,而大會亦已成為亞洲區精算業內最重要的盛事。至今為止,亞洲精算師協會由12個精算團體組成,擁有近25,000名會員。這些成員團體來自*澳洲、中國、中華台北、香港、印度、印尼、日本、馬來西亞、新加坡、南韓、泰國和菲律賓。*按英文字母順序排列由左至右:亞洲精算大會籌備委員會聯席主席林溢東先生瑞士再保險亞太區壽險與健康險再保險業務負責人(中國除外)任曉薇女士保險業監管局主席姚建華先生香港精算學會主席黃光曦先生香港特別行政區政府財經事務及庫務局副局長陳浩濂先生保險業監管局行政總監張雲正先生亞洲精算大會籌備委員會聯席主席黃建邦先生亞洲精算大會籌備委員會聯席主席王玉麟先生香港特別行政區政府財經事務及庫務局副局長陳浩濂先生致開幕辭, 為大會揭開序幕香港精算學會主席黃光曦先生歡迎來自亞洲及其他地區近1,000名精算專業人士參與是次精算界盛會  Copyright 2024 亞太商訊 via SeaPRwire.com.

三大優質資產注入 金涌投資業務多元化發展

香港, 2024年10月23日 - (亞太商訊 via SeaPRwire.com) - 金涌投資(股票代號:01328.HK)發佈公告,已於2024年10月21日舉行的股東特別大會上全票通過簽署Feasible Result、USFL及TechStar三份協議的决議案,將以總價約3,800萬美元收購弘毅集團三大優質資產。本次收購不僅可為金涌投資長期發展提供穩定的現金流支持,也標誌著金涌投資戰略升級,帶動業務多元化發展,有望為股東創造更大的價值,其中:- 金涌投資以2,600萬美元通過收購Feasible Result的 30%股權,而Feasible Result間接擁有上海利豐的100%股權,上海利豐為利豐廣場的註册擁有人。利豐廣場定位充分契合上海構建「3+6」新型產業體系規劃,已成為聚焦人工智能 + 時尚產業的活力社區,成功吸引一批科技及新經濟公司入駐,未來可帶來物業租金收入及長遠價值增長;- 公司以500萬美元間接收購USFL的32%股權,USFL的唯一資產是90.8萬股艾棣維欣股份且無任何負債。作為新三板上市公司,艾棣維欣是中國領先的生物科技企業,其研發的RSV疫苗是中國境內研發進展最快的產品之一,預計管綫商業化後將會產生穩定收益;- 公司以687.7萬美元待售股份及待售認股權證總代價收購TechStar,TechStar是一家在香港聯交所上市的特殊目的收購公司(SPAC),專注於收購中國新經濟領域的高增長企業,成功進行任何特殊目的收購公司併購交易後,將為公司提供潛在股權價值增長。今年以來,金涌投資開啓高速發展模式。年初,高子奇先生獲委任金涌投資執行董事及行政總裁,為公司發展注入全新活力,在原有基金管理業務基礎上,全新開拓企業服務、財務投資、戰略投資等模塊,推動公司的戰略升級和業務多元發展。金涌投資已先後與美圖公司、創夢天地科技控股有限公司及商湯集團股份有限公司建立戰略合作關係。未來,金涌投資還將繼續探索與其他公司進行戰略合作,尋求協同效應及共同發展的機會。在戰略提升的同時,金涌投資也致力於提升風險管理能力和改善運營效率,確保可持續增長和盈利能力。儘管上半年全球金融市場經歷市場波動,金涌投資在面對市場挑戰時展現出了强勁的韌性和增長潜力。公司上半年投資管理(IM)服務收益較去年同期增加34.3%,策略直投(SDI)業務較去年同期也錄得91.9%的大幅提升,除所得稅前利潤大幅增長36.1%。管理層表示,公司對2024年市場保持樂觀,預計SDI及IM業務將在2024年剩餘時間內繼續保持增長勢頭,公司也將充分把握中國經濟復蘇帶來的市場機遇,對未來充滿信心。而上述主要收購對提升公司基本面及市值有利,未來也不排除弘毅集團將會進一步以有利條款注入優質資產。 Copyright 2024 亞太商訊 via SeaPRwire.com.

World AI Show – Mumbai edition is set to Host AI experts and enthusiasts in Pivotal Talks on India’s AI Revolution

MUMBAI, INDIA, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - WAIS India series is to take place at the Hotel Sahara Star, Mumbai on 24th October 2024. The much-awaited one-day conference will gather 500+ AI enthusiasts and tech leaders from Pan India to seek further insights as to how “GenAI Surfaces to Power AI”.As India positions itself as a global leader in digital innovation, the 43rd Global Edition of World AI Show, an event by Trescon, will highlight how it helps the enterprises and businesses.Recent industry analysis indicates that the AI market in India is experiencing remarkable growth, with a projected compound annual growth rate of 25-35 percent by 2027. Currently valued between $7-10 billion, this market is expected to surge to approximately US$ 22 billion, underscoring India’s pivotal role in the global AI revolution. This rapid expansion highlights India's increasing influence and innovative capabilities in the field of Artificial Intelligence.In line with this transformative growth, the summit will address the opportunities and challenges within the AI landscape, focusing on three critical areas: AI ethics, the integration of Generative AI, and enhancing customer experiences. Attendees will engage in discussions about responsible AI practices, ensuring transparency and fairness, and how AI can drive seamless interactions that prioritize customer satisfaction.The World AI Show will also explore the impact of Generative AI on customer service, including its role in automating routine tasks and improving operational efficiency. Discussions will highlight how ethical AI deployment fosters trust and transparency, as well as the importance of ensuring data privacy and compliance with regulations.Attendees at the event will seek further insights on the recent advancements in Generative AI models and deliberate on critical issues such as driving successful AI transformation, preparing enterprises and businesses for AI integration, navigating the next decade of technological evolution, and shaping the future of AI.Our esteemed speaker line-up:- Sumnesh Joshi, Deputy Director General, Ministry of Communication, Government of India- Ashwini Tewari, Managing Director, State Bank of India- CP Gurnani, Co-founder & Executive Vice Chairman, AlonOS- Tapan Singhel, MD& CEO, Bajaj Allianz General Insurance- Naiyya Saggi, Group Co-Founder & Board Member, Good Glamm Group- Dr Ganesh Natarajan, Chairman, Honeywell Automation & 5F World- Dr Satyam Priyadarshy, Ex Technology Fellow, Halliburton, Founder and CEO ReigniteFuture- Abhivardhan, Founder & Chairperson, Indian Society of Artificial Intelligence & Law- Tejas Shah, Chief Information Officer, L’Oreal- Kapil Chandel, EVP & Head of Data Science, Motilal Oswal Financial Services- Guruprasad Rao, Chief Analytics & Insights Officer, Tata Power- Kiran Komatla, Group Chief Technology Officer, Restaurant Brands Asia- Ankit Goenka, Senior VP, Bajaj Allianz General Insurance- Rakesh Gupta, Head Customer Services & Customer Experience, Panasonic Electric Works India- Vishal Bhatia, Chief Digital Officer, Canara Bank- Sujatha S Iyer, Head of AI Security, ManageEngine- Shvetal Desai, Co-Founder, Nividous- Gaurav Singh, Chief Technology Advisor, Pinkerton- Madhu S Dutta, Head- Marketing Communication & Content, Raymond- Akshay Yadava, Director, Unique Identifiction Authority of India (UIDAI)- Anurag Khare, Head of Digital Marketing, Ion Exchange- Juhi Singh, Head- International Ecommerce & Global Digital Centre of Excellence, Marico“AI is crucial to India's economic blueprint, catalyzing innovation and growth across diverse sectors. With this integration, we are laying a strong foundation that pushes India forward as a leader in global technology and economic development. The World AI Show provides a crucial platform that propels this vision forward, showcasing how AI can drive substantial economic benefits and position India at the forefront of global technological innovation.” - Mithun Shetty, Vice Chairman, Trescon.Sharing his enthusiasm about speaking at the event, Sumnesh Joshi, Deputy Director General of the Ministry of Communication, Government of India said, “I am excited to speak at the World AI Show in Mumbai. This event provides an excellent opportunity to connect with a global audience and share valuable insights. I look forward to discussing how digital transformation is shaping governance and impacting the broader digital economy.”Moreover, the summit will recognize the Top 100 AI Leaders during the awards ceremony. This much-anticipated segment will recognize and honor the most impactful AI professionals in India, celebrating their outstanding leadership and exceptional contributions across various sectors. Don’t miss this chance to witness and be part of a celebration that acknowledges the individuals setting new benchmarks in AI.The 43rd Edition of the World AI Show is supported by:Platinum Partner – MAGURE Tech Middle EastGold Partner – Manage EngineSilver Partner – NividousExhibitors – ADQ, Citiuscomm, Apto.AI, SaleskenSupporting Association – Indian Society of Artificial Intelligence and LawOfficial Event Tech Partner – KONFHUBOfficial Print Partner – Business StandardAbout TresconTrescon is a pioneering force in the global business events and services sector, driving the adoption of emerging technologies while promoting sustainability and inclusive leadership. With a deep understanding of the realities and requirements of the growth markets we operate in – we strive to deliver innovative and high-quality business platforms for our clients. For more information about Trescon, visit: www.tresconglobal.comFor media inquiries and further information, please contact:Vishal S SMedia and Communications SpecialistTresconEmail: vishals@tresconglobal.comMobile: +91-7358680951 Copyright 2024 ACN Newswire via SeaPRwire.com.

TransNusa Signs Agreement with Three Renowned Medical Centres in Malaysia

JAKARTA, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - Realising yet another milestone, TransNusa has signed agreements with Sunway Medical Centre and Asia OneHealthCare with the aim to provide its passengers with additional healthcare options and thus, expanding its operations into the Medical Tourism Industry.TransNusa recently inked agreements with three medical centres allowing its passengers to enjoy additional privileges in the medical centres. The medical centres are Sunway Medical Centre, Subang Jaya Medical Centre and Ara Damansara Medical Centre. Subang Jaya Medical Centre and Ara Damansara Medical Centre are owned by Asia OneHealthCare.TransNusa Group Chief Executive Officer, Datuk Bernard Francis said, “We feel privileged to be able to expand our service offerings to include healthcare. Our Passengers will be eligible to purchase specialised and customised healthcare packages at three renowned medical centres in Malaysia.“TransNusa’ passengers can now enjoy two Signature Elite Health Screening Package, which is valued at RM1500 (USD348) at RM750 (Estimated USD174) at Sunway Medical Centre. The package price is being offered at a 50 per cent discount for TransNusa’ passenger. In addition to the discount, passengers will be able to enjoy free seat upgrades.  “In order to be eligible for the above package, our passengers will need to showcase their boarding passes when registering for the package at Sunway Medical Centre,” explained Datuk Francis.“Passengers who fly TransNusa will also be able to enjoy a 20 per cent discount for all medical check-up at Subang Jaya Medical Centre and Ara Damansara Medical Centre,” Datuk Francis continued, adding that passengers will also be able to enjoy free airport transfer from the Subang Airport to the Subang Jaya Medical Centre and Ara Damansara Medical Centre.LEADING TRANSNUSA TO GREATER HEIGHTS... Datuk Bernard Francis, Chief Executive Officer, TransNusaAll three medical centres are close to Subang Airport, with Ara Damansara Medical Centre being the closest. The medical centre is only 7.9km from the Subang Airport, which is also known as the Sultan Abdul Aziz Shah Airport. Meanwhile, Sunway Medical Centre is 14 km from the airport and Subang Jaya Medical Centre is 13km from the airport.TransNusa will be operating one daily scheduled flight from Terminal 3, Soekarno-Hatta International Airport to Subang Airport. The flight, 8B 699, will depart Jakarta at 04.10pm and arrive at the Subang Airport at 07.00pm while TransNusa flight, 8B 698, will depart Subang Airport at 07.30pm and arrive in Jakarta at 08.30pm. TransNusa will be utilizing its A320 narrow-body airliner, which has 174 seats, to cater for the two-hour scheduled flight. TransNusa ticket for this route is competitively priced from RM240 (Estimated USD54).TransNusa, which had to close it business operation in September 2020 due to impact of the Covid-19 pandemic on the aviation industry, started operations again after injection of new shareholders and management team led by Malaysian-born aviation industry veteran, Datuk Bernard Francis, in October 2022.Within 6 months, under the leadership of Datuk Francis, the airline introduced its first international route between Jakarta and Kuala Lumpur and celebrated its first-year anniversary for this route on April 14, 2024.Since the change in management team, TransNusa has been contributing and changing the aviation landscape in Indonesia. It has been making headlines in Indonesia, Malaysia, Singapore, China and around the world with news of being the first airline in Indonesia and the world to develop and introduce a new domestic route connecting Bali and Manado. TransNusa also became the second Indonesian airline to receive approval to fly to China and provided its passengers with more pricing and route options to China. In addition, the airline also became the first airline outside China to utilise the COMAC ARJ21-700.Primary Media ContactTrina Thomas Raj+6012 499 2672trina@myqaseh.orgAbout TransNusaTransNusa Airline is a Premium Service Carrier. After the take-over in February 2024, the airline rebranded itself from being a Low-Cost Carrier to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered.TransNusa, which received its AOC certification on 9th September 2022, launched its first three A320 operations on 6th October, 14th October and 12th December, 2022. The airline, which became the first outside of China to utilise Comac, received its first ARJ21 on 22nd December, 2022.  In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently based in Jakarta Soekarno-Hatta International Airport.The airline currently flies to Yogyakarta and Bali. On the international front, TransNusa flies to Singapore, Guangzhou, Kuala Lumpur and Johor. The airline became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model.Passengers can book their flights on the TransNusa website (www.transnusa.co.id), through authorized travel agents in Singapore, Malaysia and Indonesia, or by contacting the airline's customer service centre at +6221 631 0888. For the Singaporean market, passengers can contact TransNusa’s General Sales Agent, Chariot Travels Pte Ltd on +65 8660 2719, while for the Malaysian market passengers can contact MKM Ticketing Travel & Tours Sdn Bhd on +6037 831 2581. Copyright 2024 ACN Newswire via SeaPRwire.com.

T.MAN Pharmaceutical PCL (SET: TMAN) Showcases Leadership in Health Innovation, Aiming for Sustainable Growth Following Listing on SET

BANGKOK, Oct 22, 2024 - (ACN Newswire via SeaPRwire.com) - T.MAN Pharmaceutical PCL (SET: TMAN), a leader in the production and distribution of pharmaceuticals and healthcare products in Thailand for over 50 years, debuts on the Stock Exchange of Thailand (SET) under the Personal Products & Pharmaceuticals sector. The company has showcased its commitment to investing in technology to enhance production and efficiency, focusing on the research, development, and innovation of pharmaceuticals and healthcare products. Aiming to expand its market presence both domestically and internationally, the company strives to be a leader in health innovation that enhances the quality of life for all.Mr. Prapon Thanachotipan, Chief Executive Officer of T.MAN Pharmaceutical PCL ("the company" or "TMAN"), announces that the company starts trading its shares on the SET on October 22, 2024, under the consumer products industry group, specifically in the personal products and pharmaceuticals category, using the ticker symbol “TMAN”. He expresses confidence that the company’s strong foundation in health innovation, from research and development of pharmaceuticals and healthcare products to enhancing production standards with modern technology and effective marketing strategies, will make TMAN a quality stock that attracts investors. The company aims to be a leader in health innovation, helping to improve the quality of life for everyone.Following its listing, the company has allocated a short-to-medium-term investment budget not exceeding 777.5 million THB, divided as follows:1) Ongoing projects involving construction and machinery installation, totaling up to 298.5 million THB. These include:1.1) Projects to improve the efficiency of herbal product manufacturing,1.2) Projects to enhance the efficiency of modern medicine production,1.3) Expansion of research and development,1.4) Increased production capacity for dietary supplements,1.5) Development of sales systems using information technology,1.6) Procurement of quality control equipment for modern medicine,1.7) Procurement of quality control equipment for dietary supplements, and1.8) Construction of warehouses and office buildings, with several projects already underway.2) The company has also planned future investments for business expansion in 5 projects, with a budget not exceeding 479.0 million THB. These include:2.1) Construction of a new headquarters building,2.2) The first phase of expanding production capacity for modern medicine,2.3) Investment in the installation of solar panels (Solar Rooftop),2.4) Upgrading production areas for modern medicine, and2.5) The second phase of expanding production capacity for modern medicine.Mr. Prapon states that after being listed on the stock exchange, the company has strategized for sustainable growth by focusing on building brand recognition and acceptance for its products. It aims to develop pharmaceuticals for chronic non-communicable diseases (NCDs) and respiratory conditions to expand its customer base among hospitals, a major segment in the pharmaceutical industry. Currently, the company has over 226 brands. Additionally, it will continue to research and develop diverse and high-quality health innovations to fully meet customer needs. The company also plans to increase its contract manufacturing (OEM/ODM) and distribution services, while boosting revenue growth by expanding product distribution to over 22 countries worldwide, aiming to become a global brand in the future.Mr. Thinnaphan Wanglee, Deputy Managing Director of Kasikorn Securities Public Company Limited, acting as the financial advisor and lead underwriter, states that TMAN is a leading group in the production and distribution of pharmaceuticals and health products in Thailand. It is at the forefront of inventing, researching, and developing pharmaceuticals and healthcare products that fit current trends in preventive and therapeutic healthcare. TMAN has enhanced its R&D centers and production facilities with modern technology, improving its competitiveness as well as aggressively expanding its business both domestically and internationally, driven by strong business strategies that will enable sustainable growth.Analysts from leading securities firms view TMAN shares as having a solid foundation, with a diverse range of over 842 SKUs in pharmaceuticals and healthcare products, many of which are popular in the market with strong brand presence. The company plans to launch 10-12 new products annually, backed by research and development that swiftly addresses consumer needs. Strategies to expand its customer base among hospitals and penetrate international markets are expected to drive continuous sales growth both domestically and abroad. Effective cost management through direct distribution to customers also contributes to its growth. Analysts have assessed the fundamental value of TMAN shares to be in the range of 24.0-29.5 THB per share, with a positive outlook driven by the following factors: 1) Expanding product lines under existing brands, 2) Launching new products under the TMAN brand, 3) Expanding the customer base among hospitals, 4) Continuously growing distribution channels, and 5) Boosting international sales to move towards becoming a global brand.Additionally, TMAN engages in third-party distribution, which provides in-depth market and consumer behavior insights that support the company's growth. The current consumer trend toward health consciousness, which is a global megatrend, further drives this growth.Released by Public Relations Dept, MT Multimedia Co., Ltd for T.MAN Pharmaceutical PCL or TMANFor more information, please contact: Pipop (Top)Tel. +66 81-929-8864; Email: pipop.k@mtmultimedia.com T.MAN Pharmaceutical PCL [SET: TMAN; TMAN/F; TMAN-R] https://www.tmanpharma.in.th/en/home-en/  Copyright 2024 ACN Newswire via SeaPRwire.com.

BlackBerry Partners with ISC2 to Advance Cybersecurity Skills in Malaysia

KUALA LUMPUR, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - BlackBerry Limited (NYSE:BB)(TSX:BB) has announced a new partnership with The International Information System Security Certification Consortium (ISC2), the world's leading nonprofit member organization for cybersecurity professionals, to deliver its globally recognized cybersecurity training and certifications in Malaysia. In support of the Malaysian Government's ongoing efforts to boost digital skills, capacity and cyber-resilience, the courses are now offered as part of the BlackBerry Cybersecurity Curriculum at the world-class Cybersecurity Center of Excellence (CCoE) facility in Cyberjaya. Registration is now open for the first ISC2 courses taking place later this month.As Malaysia's digital transformation continues to accelerate and threat surfaces expand, so too does the demand for highly-qualified cybersecurity professionals. BlackBerry's new partnership with ISC2 extends the range of internationally-certified courses available to cyber professionals at the Malaysia CCoE to help upskill and enhance capabilities to bolster defenses against ever-evolving cyber threats. The courses include ISC2's highly sought-after Certified Information Systems Security Professionals (CISSP), Certified Cloud Security Professional (CCSP) and Certified in Cybersecurity (CC).Han Ther Lee, Director of Education and Training, Cybersecurity Center of Excellence, BlackBerry, commented, "As Malaysia prepares for the ‘Year of Skills' in 2025, BlackBerry remains committed to collaborating with government and industry to help educate, upskill and grow the nation's cyber-workforce. We are proud to partner with another top-tier training institution like ISC2, further enriching the curriculum offered at the Cybersecurity Center of Excellence and giving cyber professionals in Malaysia and the region wider access to globally recognized certifications."The first courses offered through the partnership will focus on critical cybersecurity disciplines, including security operations, risk management, and cloud security, vital to strengthening national and regional cybersecurity capabilities, especially as the region pushes forward its digital transformation goals. ISC2 will provide comprehensive training materials, course resources, licenses, and ongoing support for all its programs.Cigdem Bildirici​​​​, Vice President, Business Development, ISC2 added, "With Malaysia advancing towards a more digitally connected future and the accompanying rise in cyber risks, strengthening the cybersecurity workforce has become more vital than ever. We're excited to collaborate with BlackBerry at the Cybersecurity Center of Excellence to bring our training programs to support this growth."Since opening the CCoE in March 2024, with the support of the Malaysian Communications and Multimedia Commission (MCMC), BlackBerry and its education partners have dedicated over 8,000 hours to train over 1,500 professionals at the facility. Several education partnerships also offer globally-certified training courses at the CCoE, including CompTIA, SANS Institute and the Rogers Cybersecure Catalyst ("the Catalyst") at Toronto Metropolitan University, which runs its CLIC (Certifications of Leadership in Cybersecurity) training program.Now in its sixth month of operations, the addition of ISC2 training programs at the CCoE is another milestone achievement for the non-profit institution, which aims to provide the most comprehensive set of certifications and training courses available in the Indo-Pacific region.The first wave of ISC2 certification courses, Certified in Cybersecurity (CC) will commence by the end of October 2024, while the renowned CISSP and CCSP programs, will start in November 2024. Cybersecurity professionals and organizations across Malaysia and the Indo-Pacific region can now register for the ISC2 courses here. Additional programs, such as specialized workshops and advanced training, will be rolled out in the months to follow, providing continuous opportunities for upskilling and certification.About ISC2ISC2 is the world's leading member organization for cybersecurity professionals, driven by our vision of a safe and secure cyber world. Our nearly 675,000 members, candidates and associates around the globe are a force for good, safeguarding the way we live. Our award-winning certifications - including cybersecurity's premier certification, the CISSP® - enable professionals to demonstrate their knowledge, skills and abilities at every stage of their careers. ISC2 strengthens the influence, diversity and vitality of the cybersecurity profession through advocacy, expertise and workforce empowerment that accelerates cyber safety and security in an interconnected world. Our charitable foundation, The Center for Cyber Safety and Education, helps create more access to cyber careers and educate those most vulnerable. Learn more and get involved at ISC2.org. Connect with us on X, Facebook and LinkedIn.© 2024 ISC2 Inc., ISC2, CISSP, SSCP, CCSP, CGRC, CSSLP, HCISPP, ISSAP, ISSEP, ISSMP, CC, and CBK are registered marks of ISC2, Inc.About BlackBerryBlackBerry (NYSE:BB)(TSX:BB) provides intelligent security software and services to enterprises and governments around the world. The company's software powers over 235M vehicles. Based in Waterloo, Ontario, the company leverages AI and machine learning to deliver innovative solutions in the areas of cybersecurity, safety and data privacy, and is a leader in the areas of endpoint security management, encryption, and embedded systems. BlackBerry's vision is clear - to secure a connected future you can trust.BlackBerry. Intelligent Security. Everywhere.For more information, visit BlackBerry.com and follow @BlackBerry.Media Contact:BlackBerry Media Relations+1 (519) 597-7273mediarelations@blackBerry.comSOURCE: BlackBerry Copyright 2024 ACN Newswire via SeaPRwire.com.

ONERHT Foundation Celebrates 9th Charity Golf and Gala Dinner Event, Raising Over S$430,000 to Support 9 Charitable Organisations

SINGAPORE, Oct 22, 2024 - (ACN Newswire via SeaPRwire.com) - ONERHT Foundation Ltd, the corporate social responsibility arm of RHTLaw Asia LLP and the RHT Group of Companies (“ONERHT”), successfully raised more than S$430,000 at its 9th charity golf and gala dinner event. The funds will be directed towards the Foundation’s key initiatives, including the Ageing RigHT Project and other community programmes aimed at supporting Singapore’s ageing population and diverse community needs.Ms Evelyn Chng, Director of ONERHT Foundation, Mr Bernard Tay, Director of ONERHT Foundation, Mr Ho Peng Kee, Patron of ONERHT Foundation, Mr Tan Chong Huat, Senior Partner of RHTLaw Asia, Ms Kaylee Kwok, Chairman and Director of ONERHT Foundation, Guest-of-Honour, Deputy Prime Minister and Minister for Trade and Industry Mr Gan Kim Yong, Mr Yang Eu Jin, Director of ONERHT Foundation, Mr Azman Jaafar, Managing Partner of RHTLaw Asia at the ONERHT Charity Golf 2024 Gala Dinner. [L-R]The gala dinner, held on 18 October 2024 at Sentosa Golf Club, was honoured by the presence of Guest-of-Honour, Deputy Prime Minister and Minister for Trade and Industry Mr Gan Kim Yong. The event successfully brought together more than 200 participants, including golfers and distinguished guests from various industry sectors.This year, to mark its 9th edition of the charity golf and gala dinner event, the Foundation has pledged to support a total of 9 beneficiaries. The beneficiaries are PAP Community Foundation Sparkle Care Centres, Life Community Services Society, Singapore Cancer Society, Singapore Road Safety Council, Bethel Community Services, Singapore Christian Home, South Central Community Family Service Centre, Focus on the Family Singapore Limited and Intercultural Theatre Institute. This demonstrates the Foundation’s commitment to reach out to a wider range of charities and support more beneficiaries.Ms Kaylee Kwok, Chairman of ONERHT Foundation, emphasised the importance of the Foundation’s work: “We are profoundly grateful for the generosity of our donors and sponsors, whose unwavering support propels our mission at ONERHT Foundation. Together, we are making significant strides towards fostering positive change within our community. We remain steadfast in our commitment to our core focus areas: education, environmental and sustainability, disadvantaged groups, and the arts and sports.”The donations made to various charitable organisations will enhance their programmes and services, allowing them to better serve their communities. This commitment to supporting a diverse range of individuals highlights the importance of community-driven initiatives that make a positive impact on the lives of those in need, such as empowering youth, caring for seniors, mentoring families, and providing comprehensive healthcare services, and much more.Ms Lam Moi Kwai, CEO of Life Community Services Society, shared her gratitude. “We extend our heartfelt gratitude to the ONERHT Foundation for their generous support over the years. The Foundation’s contributions play a vital role in empowering our LCSS beneficiaries, enabling us to provide essential care and mentoring to children and families in need. We thank the Foundation for being an invaluable partner in our mission."Ms Delia Ng, CEO, Focus on the Family Singapore, also said, “Thank you ONERHT Foundation for your generous support which would enable us to expand our outreach and equipping efforts for youths who aspire to become family champions through our FamChamps movement. Youths will be inspired in hope and empowered with the necessary mindset and resilience to break cycles of dysfunction and adversity.”Mr Victor Bay, CEO of PAP Community Foundation, shared, “PCF Sparkle Care is grateful for the support from ONERHT Foundation all these years. Their generous donation has enabled us to continue to provide programmes and care to the seniors whom we are so privileged to serve.”Similarly, Mr Albert Ching, CEO, Singapore Cancer Society, said, "The Singapore Cancer Society is honoured to have ONERHT Foundation join us in the collective fight against cancer. With the number of people living with cancer on the rise, the Foundation’s generous support strengthens our efforts to provide comprehensive cancer care services to beneficiaries at every stage of their journey. This includes free cancer screenings, welfare, rehabilitation support, hospice care, and public education initiatives. Thank you, ONERHT Foundation, for helping us minimise cancer and maximise lives!”Since its establishment in 2015, ONERHT Foundation has raised over S$5 million for more than 30 beneficiaries, demonstrating its commitment to fostering a more inclusive and supportive community in Singapore.ONERHT Foundation LtdA Singapore registered charity and grant-making philanthropic organisation, ONERHT Foundation Ltd (“Foundation”) enables RHTLaw Asia LLP and the RHT Group of Companies (collectively, “ONERHT”) to do right and do good through various charitable endeavours.Set up by ONERHT in 2015, the Foundation was registered as a Singapore charity by the Commissioner of Charities and a grant-making philanthropic organisation by the Inland Revenue Authority of Singapore on 16 September 2016 and 28 November 2016 respectively.The Foundation seeks to establish, inspire and encourage the right philanthropic culture among the corporate and legal fraternity of giving back to the community in a focused, hands-on and meaningful manner. Since its inception, the Foundation has raised over S$5 million to support more than 30 beneficiaries involved in education, the environment and sustainability, disadvantaged groups as well as the arts and sports.For more information, please visit www.onerht.foundationFor media enquiries, please contact:Elliot Siow / elliot@waterbrooks.com.sg / +65 8375 0417 Copyright 2024 ACN Newswire via SeaPRwire.com.